Development
Molina Healthcare, Inc.
MOH
$296.88
$3.321.13%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 32.95B | 32.44B | 31.77B | 31.46B | 31.03B |
| Total Other Revenue | 50.00M | 62.00M | 61.00M | 60.00M | 69.00M |
| Total Revenue | 33.00B | 32.50B | 31.84B | 31.52B | 31.10B |
| Cost of Revenue | 28.67B | 28.21B | 27.65B | 27.48B | 27.18B |
| Gross Profit | 4.33B | 4.30B | 4.19B | 4.03B | 3.93B |
| SG&A Expenses | 2.46B | 2.45B | 2.40B | 2.33B | 2.31B |
| Depreciation & Amortization | 171.00M | 175.00M | 178.00M | 180.00M | 176.00M |
| Other Operating Expenses | 87.00M | 101.00M | 60.00M | 54.00M | 54.00M |
| Total Operating Expenses | 31.39B | 30.93B | 30.29B | 30.05B | 29.72B |
| Operating Income | 1.62B | 1.57B | 1.55B | 1.47B | 1.39B |
| Income Before Tax | 1.46B | 1.25B | 1.23B | 1.15B | 1.06B |
| Income Tax Expenses | 373.00M | 322.00M | 312.00M | 291.00M | 271.00M |
| Earnings from Continuing Operations | 1.09K | 931.00 | 916.00 | 855.00 | 792.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.09B | 931.00M | 916.00M | 855.00M | 792.00M |
| EBIT | 1.62B | 1.57B | 1.55B | 1.47B | 1.39B |
| EBITDA | 1.79B | 1.75B | 1.73B | 1.65B | 1.56B |
| EPS Basic | 18.89 | 16.14 | 15.89 | 14.83 | 13.69 |
| Normalized Basic EPS | 16.32 | 15.84 | 15.58 | 14.69 | 13.75 |
| EPS Diluted | 18.76 | 16.04 | 15.78 | 14.68 | 13.55 |
| Normalized Diluted EPS | 16.25 | 15.77 | 15.49 | 14.57 | 13.63 |
| Average Basic Shares Outstanding | 231.20M | 231.40M | 231.20M | 231.30M | 231.80M |
| Average Diluted Shares Outstanding | 232.20M | 232.40M | 232.60M | 233.10M | 233.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |